Medicines That Kill
A Global Industry of Fake Drugs

Resident Fellow Roger Bate
Resident Fellow
Roger Bate

U.N. health and crime agencies say counterfeit drugs are killing people from China to Canada and they "promote the development of new strains of viruses, parasites and bacteria . . . for example in the case of malaria or HIV." And in many countries their manufacture and distribution is not even illegal.

The United Nations Inter-regional Crime and Justice Research Institute (UNICRI) said this month that "the Asian and African regions seem to be the most affected by counterfeit medicines" and "more than 30 percent of medicines on sale could be counterfeits in parts of Asia and parts of Latin America while in the former Soviet republics counterfeit medicines could constitute more than 20 percent of market value."

The World Health Organization's 22-month-old International Medical Products Anti-Counterfeiting Taskforce (IMPACT) also issued its annual report this month, saying in many countries "counterfeiting medical products is not considered per se to be a serious crime" or "sanctions are sometimes much lighter than those applicable to counterfeiters of products that have no implications for health, such as T-shirts." Prosecutions need "the proven fact that counterfeits have actually resulted in injuries or death."

The growing global industry of fake and pseudo-pharmaceuticals has already defeated some legitimate cures.

Diplomatic niceties meant that the main manufacturers, China and India, were not named.

This growing global industry of fake and pseudo-pharmaceuticals has already defeated some legitimate cures: the time-tested malaria treatment chloroquine now fails most of the time in Africa because wrong doses in counterfeits have helped the parasite to evolve.

Researchers and pharmacologists around the world are working on amazing new drugs, but their efforts are undermined by the murderous opportunists who fake legitimate products. In this environment, commercial sales and donated medicines are no longer reliable.

A recent study in the Journal of Tropical Medicine and International Health estimated that 86 percent of under-strength fakes analyzed in Kenya and Congo came from India and China. Unsurprisingly, this "may be because of the laxity of Indian and Chinese regulatory bodies in checking exported medicines," it said.

Some makers are deliberate counterfeiters, faking the packaging and relabeling aspirin or chalk as a drug. But other culprits are legitimate firms that are simply slack in their operations: with more effort, they might make a perfect copy. Sometimes the entire firm is operating to low standards and at other times rogue employees work after hours to increase production and sell the drugs to criminal networks. Either way, such producers cut corners and costs by skipping the rigors of quality control.

I saw two dozen different unsound anti-malarial drugs in the pharmacies of Lagos and Abuja, the most important cities in Nigeria. One typical pharmacist carried a range of old drugs, plus some of the newer artesunate and artemisinin-combination therapies (ACTs). Only one of these had been tested by a reputable agency so one can assume the rest were useless.

But it's not just the manufacturers who bear the blame. Even some international aid agencies and donors approve drugs that have not been tested for safety or for bioequivalence (therapeutically the same as the original patented drug). The WHO had to withdraw 18 anti-retrovirals from its HIV treatment campaign in 2004 because it could not be sure the drugs were up to standard. Today the Global Fund may have to withdraw several anti-malarials from its list for the same reason.

When a Thai government factory badly copied an anti-retroviral, the resulting GPO-Vir failed to help patients but did help the virus evolve defenses--but Medecins Sans Frontieres still distributes it.

One of the heroes of the fight against counterfeits is Dora Akunyili, a 52-year-old pharmacology professor who heads Nigeria's National Agency for Food and Drug Administration and Control. Akunyili has a personal reason for fighting counterfeiters: a friend of hers died from fake anti-diabetes drugs and since then she has collected volumes of shocking tales. "People have been dying in this country from the effect of fake drugs since the early 1970s," she says.

Transparency International once ranked Nigeria as the most corrupt place on earth, but, recently, in large part due to Akunyili, it has risen from the bottom of the heap. In 2002, the WHO reported that 70 percent of drugs in Nigeria were fake or substandard: by 2004 that figure had fallen to 48 percent--still a horrifying number.

And it's not just poor countries that suffer. This time last year Canada's first death from counterfeits was caused by drugs bought off the Internet from Eastern Europe, containing contained aluminum and arsenic. In the USA, fake anemia, diabetes and cholesterol products have set off massive product recalls in the last few years.

Until international bodies clean up their act and stop blurring the boundaries between safe medicines and sub-standard copies and until there are harsh local and international penalties for manufacturing and carrying counterfeits, the pirates will continue to get away with murder.

Roger Bate is a resident fellow at AEI. He is the author of a forthcoming AEI Press book on counterfeit drugs.

Also Visit
AEIdeas Blog The American Magazine
About the Author


  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872

What's new on AEI

image The money in banking: Comparing salaries of bank and bank regulatory employees
image What Obama should say about China in Japan
image A key to college success: Involved dads
image China takes the fight to space
AEI on Facebook
Events Calendar
  • 21
  • 22
  • 23
  • 24
  • 25
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Event Registration is Closed
Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.